Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 359

The DOI matches its Crossref record.

Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies.

Brattsand, R, Linden, M·1996·Alimentary Pharmacology & Therapeutics

Abstract

Glucocorticoids inhibit the expression and action of most cytokines. This is part of the in vivo feed‐back system between inflammation‐ derived cytokines and CNS‐adrenal produced corticosteroids with the probable physiological relevance to balance parts of the host defence and anti‐inflammatory systems of the body. Glucocorticoids modulate cytokine expression by a combination of genomic mechanisms. The activated glucocorticoid‐receptor complex can (i) bind to and inactivate key proinflammatory transcription factors (e.g. AP‐1, NF kappa B). This takes place at the promotor responsive elements of these factors, but has also been reported without the presence of DNA; (ii) via glucocorticoid responsive elements (GRE), upregulate the expression of cytokine inhibitory proteins, e.g. I kappa B, which inactivates the transcription factor NF kappa B and thereby the secondary expression of a series of cytokines; (iii) reduce the half‐life time and utility of cytokine mRNAs. In studies with triggered human blood mononuclear cells in culture, glucocorticoids strongly diminish the production of the 'initial phase' cytokines IL‐1 beta and TNF‐alpha and the 'immunomodulatory' cytokines IL‐2, IL‐3, IL‐4, IL‐5, IL‐10, IL‐12 and IFN‐gamma, as well as of IL‐6, IL‐8 and the growth factor GM‐CSF. While steroid treatment broadly attenuates cytokine production, it cannot modulate it selectively, e.g. just the TH0, the TH1 or the TH2 pathways. The production of the 'anti‐inflammatory' IL‐10 is also inhibited. The exceptions of steroid down‐regulatory activity on cytokine expression seem to affect 'repair phase' cytokines like TGF‐ beta and PDGF. These are even reported to be upregulated, which may explain the rather weak steroid dampening action on healing and fibrotic processes. Some growth factors, e.g. G‐CSF and M‐CSF, are only weakly affected. In addition to diminishing the production of a cytokine, steroids can also often inhibit its subsequent actions. Because cytokines work in cascades, this means that steroid treatment can block expression of the subsequent cytokines. The blocked cytokine activity does not depend on a reduced cytokine receptor expression; in fact available in vitro investigations show that while the cytokine expression is blunted, its receptor is upregulated. The cellular studies presented here may represent the maximum potential of steroids to modulate cytokine expression in human mononuclear cells. It remains to be determined by clinical‐experimental studies how effective cytokine modulation can be achieved in situ in inflamed bowel by systemic or by topical steroid therapy. Such studies may also answer whether a blocked cytokine production/action is the key or just a secondary mechanism behind the unique efficacy of steroids in active inflammatory bowel disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.1996.22164025.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 359

Metadata

Authors
Brattsand, R., & Linden, M.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1996-01
Volume
10
Issue
Sup2
Pages
81-90
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2125566475
Cited by
359
References
0
FWCI
7.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. https://app.cochat.ai/papers/10.1046/j.1365-2036.1996.22164025.x
The paper
Brattsand, R., & Linden, M. (1996). Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1996.22164025.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.